1-cyclopropyl-4-isocyanatobenzene | 1629128-24-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-cyclopropyl-4-isocyanatobenzene
• CAS: 1629128-24-0
• 化学式: C₁₀H₉NO
• 分子量: 159.188
• InChiKey: VWOOCUCYLRCKDX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-bromo-3-cyclopropyl-2-propoxyaniline 、 1-cyclopropyl-4-isocyanatobenzene 以 四氢呋喃 为溶剂， 反应 2.0h， 以76%的产率得到1-(5-bromo-3-cyclopropyl-2-propoxyphenyl)-3-(4-cyclopropylphenyl)urea
  参考文献：
  名称：

  [EN] IDO INHIBITORS
  [FR] INHIBITEURS DE L'IDO

  摘要：

  公开了化合物(I)的结构，该化合物调节或抑制色氨酸2,3-二氧化酶(IDO)的酶活性，包含该化合物的药物组合物以及利用该发明的化合物治疗增殖性疾病，如癌症、病毒感染和/或炎症性疾病的方法。

  公开号：

  WO2015002918A1

文献信息

• [EN] IDO INHIBITORS<br/>[FR] INHIBITEURS D'IDO
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2015031295A1

  公开（公告）日：2015-03-05

  There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.

  所公开的化合物能够调节或抑制吲哚胺2,3-双加氧酶（IDO）的酶活性，包含该化合物的药物组合物以及使用本发明的化合物治疗增殖性疾病的方法，如癌症、病毒感染和/或自身免疫疾病。
• IDO INHIBITORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20160137595A1

  公开（公告）日：2016-05-19

  There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine 2,3-di-oxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

  公开了化合物(I)的公式，该化合物调节或抑制吲哚胺2,3-二氧化酶(IDO)的酶活性，含有该化合物的药物组合物以及利用本发明的化合物治疗增生性疾病，如癌症、病毒感染和/或炎症性疾病的方法。
• SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS
  申请人：Enevate Corporation

  公开号：US20210249689A1

  公开（公告）日：2021-08-12

  Electrolytes and electrolyte additives for energy storage devices comprising cyanate based compounds are disclosed. The energy storage device comprises a first electrode and a second electrode, wherein at least one of the first electrode and the second electrode is a Si-based electrode, a separator between the first electrode and the second electrode, an electrolyte comprising at least two electrolyte co-solvents, wherein at least one electrolyte co-solvent comprises a cyanate based compound.
• SMALL MOLECULE MODULATORS OF PANK
  申请人：St. Jude Children's Research Hospital

  公开号：US20220185796A1

  公开（公告）日：2022-06-16

  The present disclosure relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders (such as diabetes mellitus type II), neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
• US9765018B2
  申请人：——

  公开号：US9765018B2

  公开（公告）日：2017-09-19